2023 PCE Oncology Winter Conference

PCE, the national leader in continuing education for NPs and PAs, returns in January with our virtual Winter Oncology Conference. This complimentary CE/CME meeting is tailored to meet the clinical needs and evolving scope of practice of NPs, PAs, and nurses who practice in oncology.

Share

Program Content

Activities

  • Patient Resource
    Point of Care Resource for Patients With MDS, Prostate, Lung, Renal Cell, and Triple-Negative Breast Cancer
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 27, 2023

Activities

Advanced RCC
Keeping Up With the Rapid Emergence of Strategies for Advanced Renal Cell Carcinoma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 27, 2023

Strategies for Advanced RCC
Keeping Up With The Rapid Emergence of Strategies for Advanced Renal Cell Carcinoma
Video
Congratulations: You achieved a completion on 04/09/2022

Released: April 11, 2023

Expires: April 10, 2024

Activities

Biomarkers in NSCLC
Biomarker Testing in NSCLC: Who, What, When?
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 27, 2023

Biomarkers in NSCLC
Biomarker Testing in NSCLC: Who, What, When?
Video
Congratulations: You achieved a completion on 04/09/2022

Released: April 17, 2023

Expires: April 16, 2024

Activities

TNBC: Novel Agents
Introducing Novel Agents Into the Armamentarium for Triple-Negative Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 27, 2023

TNBC: Novel Agents
Introducing Novel Agents Into the Armamentarium for Triple-Negative Breast Cancer
Video
Congratulations: You achieved a completion on 04/09/2022

Released: April 13, 2023

Expires: April 12, 2024

Activities

Metastatic CSPC
Improving the Odds in Metastatic Castrate-Sensitive Prostate Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 27, 2023

Improving Odds in mCSPC
Improving the Odds in Metastatic Castrate-Sensitive Prostate Cancer
Video
Congratulations: You achieved a completion on 04/09/2022

Released: April 05, 2023

Expires: April 04, 2024

Activities

MDS: Novel Tx Approaches
Challenges in Myelodysplastic Syndromes (MDS): Risk Stratification and Integrating Novel Treatment Approaches
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 27, 2023

Expires: January 26, 2024

Challenges in MDS
Challenges in Myelodysplastic Syndromes (MDS): Risk Stratification and Integrating Novel Treatment Approaches
Video
Congratulations: You achieved a completion on 04/09/2022

Released: April 25, 2023

Expires: April 24, 2024

Faculty

cover img faculity

Mary Weinstein Dunn, MSN

Nurse Practitioner
Department of Urology and Medicine, Division of Oncology
University of North Carolina Chapel Hill
Chapel Hill, North Carolina

cover img faculity

Rasheda Persinger, MSN, AGNP-C, AOCNP

Medical Oncology Lead Nurse Practitioner
Sidney Kimmel Cancer Center Sibley Memorial Hospital
Johns Hopkins System
Washington, DC

cover img faculity

Laura M. Spring, MD

Breast Medical Oncologist
Mass General Cancer Center
Harvard Medical School
Boston, Massachusetts

cover img faculity

Sara Tinsley-Vance, PhD, MSN, APRN-BC, AOCN

Nurse Practitioner and Researcher
Malignant Hematology
Moffitt Cancer Center
Tampa, Florida

cover img faculity

Sarah Traverso, MMS, PA-C

Physician Assistant
Division of Genitourinary Oncology
Northwestern Medicine
Chicago, Illinois

cover img faculity

Terran Sims, MSN, ACNP-C, CNN, COCN-C

NP GU Oncology
Department of Urology
University of Virginia Health System
Charlottesville, Virginia

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Smart Patients

Supporters

This program is supported by educational grants from Amgen, Bayer HealthCare Pharmaceuticals Inc., Exelixis, Inc., Gilead Sciences, Inc., and Karyopharm Therapeutics Inc.

Amgen

Bayer HealthCare Pharmaceuticals Inc.

Exelixis, Inc.

Gilead Sciences, Inc.

Karyopharm Therapeutics Inc.

Partners

Smart Patients

ProCE Banner